Kepler Diagnostics, Inc. is empowering the global community to improve research, health and wellness by providing access to accurate and cost-effective specimen collection devices. Based in Simi Valley, California, Kepler Diagnostics is a leader in the development, manufacture and distribution of Samplla™, a portfolio of innovative collection devices and stabilization procedures designed to “freeze” time and stabilized sensitive analytes in blood to enable essential diagnostics when it needed most.
Avi A. Dukler, PhD – Co-Founder, CEO
Avi is the Co-Founder and CEO of Kepler Diagnostics. Avi has 20 years in the IVD industry. Prior to Kepler Diagnostics, he founded and served as CEO of Glycominds. Avi took Glycominds public via an IPO (TASE: GLMC), sold it to Medivie Therapeutic, did a management buy-out of the gastroenterology product line which was licensed to LabCorp (NYSE: LH).
Randy A. Ringold, B.Sc., MT, MBA – Co-Founder, CTO
Randy is the Co-Founder CTO of Kepler Diagnostics. Randy has 30+ years in the IVD industry and has held senior level management positions with Baxter Healthcare, Sysmex International and Quest Diagnostics Nichols Institute. Prior to Kepler Diagnostics, Randy was the Founder and President of VDI Laboratory, a company dedicated to the development and commercialization of innovative biomarkers for the companion animal market of which the Cardio panel rights were sold to IDEXX Laboratories (Nasdaq: IDXX).